HIV-exposed uninfected infants show robust memory B cell responses in spite of a delayed accumulation of memory B cells: An observational study in the first two years of life.

Article English OPEN
Nduati, Eunice W ; Nkumama, Irene N ; Gambo, Faith K ; Mueuma, Daniel M ; Knight, Miguel G ; Hassan, Amin S ; Jahangir, Margaret N ; Etyang, Timothy J ; Berkley, James A ; Urban, Britta (2016)
  • Publisher: American Society for Microbiology
  • Journal: Clinical and Vaccine Immunology, volume 23, issue 7, pages 576-585 (issn: 1556-6811, eissn: 1556-679X)
  • Related identifiers: pmc: PMC4933775, doi: 10.1128/CVI.00149-16
  • Subject: wh_200 | Clinical Immunology | wc_503 | qw_504 | Spotlight | ws_430

Improved HIV care has led to an increase in the number of HIV-exposed uninfected (HEU) infants born to HIV-infected women. Although they are uninfected, these infants experience increased morbidity and mortality. One explanation may be that their developing immune system is altered by HIV exposure, predisposing them to increased postnatal infections. We explored the impact of HIV exposure on the B-cell compartment by determining the B-cell subset distribution, the frequency of common vaccine antigen-specific memory B cells (MBCs), and the levels of antibodies to the respective antigens in HEU and HIV-unexposed uninfected (HUU) infants born to uninfected mothers, using flow cytometry, a B-cell enzyme-linked immunosorbent spot assay, and an enzyme-linked immunosorbent assay, respectively, during the first 2 years of life. For the majority of the B-cell subsets, there were no differences between HEU and HUU infants. However, HIV exposure was associated with a lower proportion of B cells in general and MBCs in particular, largely due to a lower proportion of unswitched memory B cells. This reduction was maintained even after correcting for age. These phenotypic differences in the MBC compartment did not affect the ability of HEU infants to generate recall responses to previously encountered antigens or reduce the antigen-specific antibody levels at 18 months of life. Although HIV exposure was associated with a transient reduction in the proportion of MBCs, we found that the ability of HEU infants to mount robust MBC and serological responses was unaffected.
  • References (62)
    62 references, page 1 of 7

    1. Nesheim S, Harris LF, Lampe M. 2013. Elimination of perinatal HIV infection in the USA and other high-income countries: achievements and challenges. Curr Opin HIV AIDS 8:447- 456. http://dx.doi.org/10.1097 /COH.0b013e3283636ccb.

    2. Joint United Nations Programme on HIV/AIDS. 2011. World AIDS Day report: how to get to zero: Faster. Smarter. Better. Joint United Nations Programme on HIV/AIDS, Geneva, Switzerland.

    3. Shapiro RL, Lockman S. 2010. Mortality among HIV-exposed infants: the first and final frontier. Clin Infect Dis 50:445- 447. http://dx.doi.org /10.1086/649887.

    4. Marinda E, Humphrey JH, Iliff PJ, Mutasa K, Nathoo KJ, Piwoz EG, Moulton LH, Salama P, Ward BJ, Group ZS. 2007. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J 26:519 -526. http://dx.doi.org/10.1097/01.inf.0000264527.69954.4c.

    5. Slogrove A, Reikie B, Naidoo S, De Beer C, Ho K, Cotton M, Bettinger J, Speert D, Esser M, Kollmann T. 2012. HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life. J Trop Pediatr 58:505-508. http://dx.doi.org/10.1093/tropej/fms019.

    6. Taron-Brocard C, Le Chenadec J, Faye A, Dollfus C, Goetghebuer T, Gajdos V, Labaune JM, Perilhou A, Mandelbrot L, Blanche S, Warszawski J, France Recherche Nord & Sud Sida-HIV HepatitesEnquete Perinatale Francaise-CO1/CO11 Study Group. 2014. Increased risk of serious bacterial infections due to maternal immunosuppression in HIV-exposed uninfected infants in a European country. Clin Infect Dis 59:1332-1345. http://dx.doi.org/10.1093/cid/ciu586.

    7. Mussi-Pinhata MM, Freimanis L, Yamamoto AY, Korelitz J, Pinto JA, Cruz ML, Losso MH, Read JS, National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study Group. 2007. Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative perinatal study. Pediatrics 119:e694 - e704. http://dx.doi.org/10.1542/peds.2006-1856.

    8. von Mollendorf C, von Gottberg A, Tempia S, Meiring S, de Gouveia L, Quan V, Lengana S, Avenant T, du Plessis N, Eley B, Finlayson H, Reubenson G, Moshe M, O'Brien KL, Klugman KP, Whitney CG, Cohen C, Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa. 2015. Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged 1 year in South Africa, 2009-2013. Clin Infect Dis 60:1346 -1356. http://dx.doi.org/10.1093/cid/civ059.

    9. Dauby N, Goetghebuer T, Kollmann TR, Levy J, Marchant A. 2012. Uninfected but not unaffected: chronic maternal infections during pregnancy, fetal immunity, and susceptibility to postnatal infections. Lancet Infect Dis 12:330 -340. http://dx.doi.org/10.1016/S1473 -3099(11)70341-3.

    10. Afran L, Garcia Knight M, Nduati E, Urban BC, Heyderman RS, Rowland-Jones SL. 2014. HIV-exposed uninfected children: a growing population with a vulnerable immune system? Clin Exp Immunol 176:11- 22. http://dx.doi.org/10.1111/cei.12251.

  • Related Research Results (1)
  • Metrics
    No metrics available